Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Uxin (UXIN) EBIT (2017 - 2025)

Uxin filings provide 9 years of EBIT readings, the most recent being -$8277.3 billion for Q4 2025.

  • On a quarterly basis, EBIT fell 82336044.51% to -$8277.3 billion in Q4 2025 year-over-year; TTM through Dec 2025 was -$8277.3 billion, a 20926753.34% decrease, with the full-year FY2025 number at -$24.5 million, up 37.18% from a year prior.
  • EBIT hit -$8277.3 billion in Q4 2025 for Uxin, down from -$5095.4 in the prior quarter.
  • In the past five years, EBIT ranged from a high of $19.0 billion in Q1 2021 to a low of -$8277.3 billion in Q4 2025.
  • Median EBIT over the past 5 years was -$14475.0 (2022), compared with a mean of -$413.8 billion.
  • Biggest five-year swings in EBIT: skyrocketed 6160.95% in 2021 and later crashed 82336044.51% in 2025.
  • Uxin's EBIT stood at -$11391.6 in 2021, then decreased by 22.88% to -$13998.0 in 2022, then grew by 26.46% to -$10294.0 in 2023, then tumbled by 97558.83% to -$10.1 million in 2024, then crashed by 82336044.51% to -$8277.3 billion in 2025.
  • The last three reported values for EBIT were -$8277.3 billion (Q4 2025), -$5095.4 (Q3 2025), and -$6.0 million (Q2 2025) per Business Quant data.